| |
Company
Roster
|
|
Total
Insiders : |
22 |
|
|
|
Total
Direct Shares :
|
10,330,475 |
|
|
Total
Indirect Shares :
|
11,784,513 |
| |
%
Held by Insiders:
|
34.79% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Martell Ron |
President and CEO |
2013-01-01 |
25,000 |
2013-01-01 |
0 |
| Ghiglieri Stephen F |
Exec. V.P., COO & CFO |
2012-12-01 |
54,198 |
2012-12-01 |
32,095 |
| Peroutka Stephen J |
Vice President and CMO |
2012-11-09 |
18,750 |
2012-11-09 |
0 |
| Markels Michael |
Senior VP,Commercial & Bus Dev |
2012-09-01 |
69,873 |
2007-11-19 |
0 |
| Bienaime Jean Jacques |
Director |
2011-07-26 |
21,748 |
|
0 |
| Goodwin Bradford S |
Director |
2011-07-26 |
75,000 |
2010-06-07 |
0 |
| Nelsen Robert |
Director, 10% Owner |
2011-07-21 |
4,187,777 |
2011-07-26 |
4,187,777 |
| Tobias Jeffrey K |
EVP Research & Dev & CMO |
2011-05-18 |
4,999 |
2009-11-25 |
0 |
| Ditonno Anthony A |
President, CEO & Director, Director |
2011-02-08 |
8,617 |
2011-02-08 |
96,000 |
| Arkin Moshe |
also member of 10% owner group, 10% Owner |
2010-09-09 |
2,648,107 |
2010-09-09 |
0 |
| Sv Life Sciences Fund Iv (gp), L.p. |
10% Owner |
2010-05-03 |
61,324 |
2009-09-15 |
2,521,315 |
| M. Arkin (1999) Ltd. |
member of 10% owner group |
2010-02-10 |
2,618,107 |
2011-08-10 |
0 |
| Senator Ron |
member of 10% owner group |
2009-09-11 |
0 |
2011-08-10 |
0 |
| Bley Keith R |
SVP Nonclinical R & D |
2007-05-07 |
56,785 |
|
0 |
| Alta Biopharma Partners Iii Gmbh & Co Beteiligungs |
10% Owner |
2007-05-07 |
0 |
2007-05-07 |
1,735,673 |
| Harder Karen J |
SVP, Reg Affairs |
2007-05-07 |
21,287 |
|
0 |
| Nohra Guy P |
10% Owner |
2007-05-07 |
0 |
2007-05-07 |
1,735,673 |
| Lazarus Steven |
10% Owner |
2007-05-07 |
458,903 |
2007-05-02 |
0 |
| Turner Daniel K III |
Director |
2007-05-07 |
0 |
2007-05-07 |
488,100 |
| Kawahata Russell T |
|
|
0 |
|
0 |
| Deerfield Special Situations Fund International Lt |
10% Owner |
|
0 |
2009-07-13 |
987,880 |
| Rinne Susan P |
|
|
0 |
|
0 |
|
